Skip to main content

ALVOW · Alvotech · Webcasts, Transcripts & Audio

Track ALVOW — free
$0.14 At close · Nov 6 Play latest call Q2 2026 earnings call transcript
Market Cap
$1.73B
Shares
356.82M
Volume · Nov 6 216 Avg daily vol (3M) 2935

Alvotech Webcasts

Earnings calls, investor updates, investor days and conferences for Alvotech (ALVOW), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY26 · Q4
2027-03-11
Alvotech (ALVOW) Q4 2026 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY26 · Q3
2026-11-12
Alvotech (ALVOW) Q3 2026 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-08-20
Alvotech (ALVOW) Q2 2026 Earnings Call Transcript
Positive tone Pipeline and upcoming submissions Guidance reaffirmation and quarterly cadence Manufacturing ramp-up after facility improvements
Results not yet reported
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-08
Alvotech (ALVOW) June 8, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-04
Alvotech (ALVOW) June 4, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-03-19
Alvotech (ALVOW) Q4 2025 Earnings Call Transcript
Positive tone Pipeline submissions and approvals FDA inspection and BLA resubmissions Geographic expansion
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Date not confirmed
Alvotech (ALVOW) Q3 2025 Earnings Call Transcript
Positive tone FDA Complete Response Letter for Simponi biosimilar Biosimilar pipeline and development programs Reykjavik facility inspection and remediation
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Date not confirmed
Alvotech (ALVOW) Q2 2025 Earnings Call Transcript
Confident tone Financial performance and growth Humira biosimilar (SIMLANDI/HUKYNDRA) STELARA biosimilar (AVT04)
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Date not confirmed
Alvotech (ALVOW) Q1 2025 Earnings Call Transcript
Confident tone Stelara biosimilar launch and interchangeable designation Humira / SIMLANDI commercial performance Capacity / manufacturing scale
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q3
2024-09-30
Date not confirmed
Alvotech (ALVOW) Q3 2024 Earnings Call Transcript
Confident tone Pipeline Advancement 2025 Revenue Guidance FDA Inspection and Compliance
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
Date not confirmed
Alvotech (ALVOW) Q2 2024 Earnings Call Transcript
Confident tone US Humira (adalimumab) biosimilar ramp Pipeline expansion and upcoming submissions Stelara biosimilar (SELARSDI / AVT04)
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Date not confirmed
Alvotech (ALVOW) Q1 2024 Earnings Call Transcript
Confident tone Humira biosimilar (AVT02) U.S. launch Stelara biosimilar (AVT04/Selarsdi) global launches Pipeline expansion and new filings
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Date not confirmed
Alvotech (ALVOW) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Date not confirmed
Alvotech (ALVOW) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Date not confirmed
Alvotech (ALVOW) Q2 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Date not confirmed
Alvotech (ALVOW) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Date not confirmed
Alvotech (ALVOW) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Date not confirmed
Alvotech (ALVOW) Q3 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
Date not confirmed
Alvotech (ALVOW) Q2 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–19 of 19 webcasts
Key facts CIK 1898416 CUSIP L01800108 13F (30d) 2 filings 2 filers Visit website Investor relations